Philips CPAP Machine Recall – Potential Cancer Risk
By Consider The Consumer on 03/15/2022
Philips CPAP Machine Recalled Due to Potential Health Risks
Philips Respironics announced they would be recalling their CPAP, BiPAP, and ventilator machines in June 2021 after realizing potential health risks. This recall included millions of sleep apnea machines sold prior to April 2021.
The recalled parts are constructed with a foam part that may degrade and produce toxic gases. If inhaled, these gases can lead to severe health difficulties, including cancer.
You may have a legal claim if you have used one of these machines and were diagnosed with cancer or any type of lung injury after the fact.
The Philips machines impacted by this recall include:
- DreamStation ASV
- DreamStation ST, AVAPS
- SystemOne ASV4
- C-Series ASV
- C-Series S/T and AVAPS
- OmniLab Advanced+
- SystemOne (Q-Series)
- DreamStation Go
- Dorma 400
- Dorma 500
- REMstar SE Auto
- Trilogy 100
- Trilogy 200
- Garbin Plus, Aeris, LifeVent
- A-Series BiPAP Hybrid A30 (not marketed in US)
- A-Series BiPAP V30 Auto
- A-Series BiPAP A40
- A-Series BiPAP A30
Recommendations for Individuals Who Use Recalled Products
If you have used any of the recalled Philips machines or ventilators, it is recommended you speak to your health care provider or physician to determine the best possible treatment options.
Editor’s Note on Philips CPAP Machine Recall:
This article is written to inform you of the Philips CPAP Machine Recall due to health risks.
Have you used the affected Philips machines and/or ventilators? Tell us by clicking the “Contact Us” button below!
You can also reach out to us on Twitter or Facebook or via email at Outreach@ConsiderTheConsumer.com. Also, directly on our website! We look forward to hearing from you.
Leave a Reply